1. Home
  2. KOSS vs ATNM Comparison

KOSS vs ATNM Comparison

Compare KOSS & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

N/A

Current Price

$4.06

Market Cap

39.3M

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.21

Market Cap

36.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOSS
ATNM
Founded
1953
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
36.8M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
KOSS
ATNM
Price
$4.06
$1.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
16.8K
115.6K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
10.00
30.60
EPS
N/A
N/A
Revenue
$12,624,170.00
$81,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.93
N/A
52 Week Low
$4.00
$1.02
52 Week High
$8.59
$1.95

Technical Indicators

Market Signals
Indicator
KOSS
ATNM
Relative Strength Index (RSI) 42.04 52.28
Support Level $4.07 $1.02
Resistance Level $5.04 $1.71
Average True Range (ATR) 0.14 0.07
MACD -0.01 0.02
Stochastic Oscillator 18.42 77.78

Price Performance

Historical Comparison
KOSS
ATNM

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: